Dr. Iris Good is a scientist-entrepreneur and investor, specialising in commercialisation of medical devices in India for over 20 years. She has established and brought to growth several medical device companies and has been a non-executive director in several countries. Iris is chair of Imperial Innovations Seed Fund, of London Business School HealthTech Challenge, of Good Relations India and is a member of the investment committee of Cambridge University Seed Fund.

Iris is inspirational in how much she has accomplished from her work as a scientist, entrepreneur and now investor. We talk about her experience transitioning into these roles, lessons she's learned and failures she's experienced, qualities of good startups and scientist entrepreneurs, new initiatives from technology transfer organizations, her experience as a woman in science, and much more.  

More about Iris 

Soon after completing her Ph.D. in Biochemistry from the Weizmann Institute of Science, followed by two post docs (molecular biology and brain research) Iris moved to technology commercialisation in international markets. She co-established UltraShape (high-intensity ultrasound device for fat emulsification), acquired by Syneron Medical Ltd, and led the business development of MetaCure (a diabetic pace-maker). She took MetaCure to India, setting up pan-India clinical-trials and commercial operations. She founded I-Connections, an India market-entry firm focusing on cutting edge technologies, establishing strategic partnerships and commercial expansions. I-Connections later merged with Good Relations India, a 33-years old award-winning Strategic PR & Market Entry consultancy with offices in Mumbai, Delhi, Bangalore, Chennai and London, providing full strategy and execution to international companies in India. Iris became its chair in 2008. Good Relations India has handled leading clients such as Apple, Barclays, Bloomberg, Cartier, CNBC, Etihad, The UN and Virgin Atlantic and hundreds of start-ups. The company brought Marks & Spencer to India and created their JV with Reliance Industries, Sun Life Insurance with Birla Group, Scottish & Newcastle with Kingfisher and many others.

In recent years Iris has served on boards of Sight Diagnostics, Step of Mind and Tikal Networks (Israel) on the advisory board of Trapezia Capital and Puridify Ltd and on the main board of Accloud and Touchlight Genetics (UK). She has been active mentor/judge/investor in London Business School, Judge Business School, Oxford Foundry and Imperial College. She is a member of the Cambridge Seed Fund investment committee since 2018 and chairs the Imperials College Seed Fund since 2020.

Find Iris on LinkedIn. 

Join the Bountiful community today and realize your power to save the world.

Don't forget to follow us on Twitter and LinkedIn if you haven't already.